Heejeong Kim
Vice President, Head of Drug Substance, Samsung Biologics
Vice President, Head of Drug Substance, Samsung Biologics
October 6, 2025
From identifying process deviations to accelerating scale up, digital twins offer significant advantages in bioprocessing.
6 min read
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
